Ardelyx, Inc. (ARDX)

3.78 +0.07 (+1.89%) USD  |  NASDAQ  |  Sep 04, 16:00
3.775 0.00 (0.00%) After-Hours: 20:00
More

Ardelyx SG&A Expense (TTM) : 373.73M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ARDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 373.73M
March 31, 2026 356.28M
December 31, 2025 337.23M
September 30, 2025 326.90M
June 30, 2025 308.25M
March 31, 2025 288.92M
December 31, 2024 258.69M
September 30, 2024 230.37M
June 30, 2024 198.06M
March 31, 2024 160.59M
December 31, 2023 134.40M
September 30, 2023 106.38M
June 30, 2023 92.39M
March 31, 2023 84.06M
December 31, 2022 76.60M
September 30, 2022 72.20M
June 30, 2022 73.25M
March 31, 2022 74.51M
December 31, 2021 72.30M
September 30, 2021 68.31M
June 30, 2021 56.23M
March 31, 2021 43.15M
December 31, 2020 33.15M
September 30, 2020 28.67M
June 30, 2020 27.96M
Date Value
March 31, 2020 26.29M
December 31, 2019 24.27M
September 30, 2019 22.84M
June 30, 2019 21.87M
March 31, 2019 22.64M
December 31, 2018 23.72M
September 30, 2018 23.77M
June 30, 2018 23.67M
March 31, 2018 23.38M
December 31, 2017 23.23M
September 30, 2017 23.02M
June 30, 2017 21.50M
March 31, 2017 20.50M
December 31, 2016 18.73M
September 30, 2016 17.56M
June 30, 2016 16.60M
March 31, 2016 14.64M
December 31, 2015 13.53M
September 30, 2015 12.32M
June 30, 2015 10.77M
March 31, 2015 9.085M
December 31, 2014 7.287M
September 30, 2014 5.43M
June 30, 2014 3.607M
March 31, 2014 2.404M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
REGENXBIO, Inc. 85.56M
ACADIA Pharmaceuticals, Inc. 620.29M
Alnylam Pharmaceuticals, Inc. 1.318B
Anika Therapeutics, Inc. 52.67M
Savara, Inc. 56.71M